ANJALI BAKSHI
Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease BROOKLYN, NY NPI 1801080957
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease NY Amgen Inc. All categories
General Payments — all program years on this page
$3,068.97
- Category: General Payments
- Program years: PY2018–2024
- Record count: 38
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $984.38 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $984.38 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $247.15 | 2 |
| Xeris Pharmaceuticals, Inc. | $243.31 | 2 |
| Janssen Pharmaceuticals, Inc | $126.72 | 1 |
| SANOFI-AVENTIS U.S. LLC | $125.00 | 1 |
| ViiV Healthcare Company | $125.00 | 1 |
| Abbott Laboratories | $117.20 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078105652 | Janssen Pharmaceuticals, Inc | $126.72 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111523197 | Amgen Inc. | $124.96 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111523199 | Amgen Inc. | $122.19 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1112723482 | ViiV Healthcare Company | $125.00 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125278127 | Abbott Laboratories | $117.20 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139988471 | SANOFI-AVENTIS U.S. LLC | $125.00 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144586974 | Xeris Pharmaceuticals, Inc. | $118.31 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144586976 | Xeris Pharmaceuticals, Inc. | $125.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.